Stephen Bridgett, James Campbell, Christopher J. Lord, Colm J. Ryan 

Slides:



Advertisements
Similar presentations
Basic features for portal users. Agenda - Basic features Overview –features and navigation Browsing data –Files and Samples Gene Summary pages Performing.
Advertisements

CCLE Cancer Cell Line Encyclopedia Alexey Erohskin.
Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data  Julia L. Williams, Peter A. Greer,
Hyunghoon Cho, Bonnie Berger, Jian Peng  Cell Systems 
Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data  Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael.
Volume 15, Issue 3, Pages (April 2016)
Volume 5, Issue 1, Pages (October 2013)
Carlos L. Arteaga, Jeffrey A. Engelman  Cancer Cell 
Ruth B. McCole, Jelena Erceg, Wren Saylor, Chao-ting Wu  Cell Reports 
Volume 6, Issue 5, Pages e5 (May 2018)
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 27, Issue 3, Pages (March 2015)
Coding of the Reach Vector in Parietal Area 5d
Identification of Small Exonic CNV from Whole-Exome Sequence Data and Application to Autism Spectrum Disorder  Christopher S. Poultney, Arthur P. Goldberg,
William M. Lin, Julia M. Lewis, Renata B. Filler, Badri G
Volume 5, Issue 4, Pages e5 (October 2017)
Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity  Kenichi.
ASSIGNMENT 10 Use the UP and DOWN tags as provided and query the LINCS. These are the KRAS-DEP (UP) and KRAS-IND (DOWN) gene signatures from Singh et al.
Transcriptional Addiction in Cancer
Translation of Genotype to Phenotype by a Hierarchy of Cell Subsystems
Volume 23, Issue 4, Pages (April 2018)
Volume 31, Issue 2, Pages (February 2017)
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Anastasia Baryshnikova  Cell Systems 
A Biomarker Harvest from One Thousand Cancer Cell Lines
Yang Liu, Perry Palmedo, Qing Ye, Bonnie Berger, Jian Peng 
Volume 4, Issue 3, Pages (August 2013)
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Global Edgetic Rewiring in Cancer Networks
Objective, Quantitative, Data-Driven Assessment of Chemical Probes
Volume 24, Issue 4, Pages (July 2018)
Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility.
Integrative Multi-omic Analysis of Human Platelet eQTLs Reveals Alternative Start Site in Mitofusin 2  Lukas M. Simon, Edward S. Chen, Leonard C. Edelstein,
Personalized Medicine: Patient-Predictive Panel Power
Fast, Quantitative and Variant Enabled Mapping of Peptides to Genomes
by Alex J. Cornish, Phuc H. Hoang, Sara E. Dobbins, Philip J
Volume 14, Issue 7, Pages (February 2016)
Volume 155, Issue 4, Pages (November 2013)
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines
Volume 5, Issue 4, Pages e4 (October 2017)
Volume 24, Issue 7, Pages (August 2018)
Volume 25, Issue 3, Pages e6 (October 2018)
Volume 9, Issue 1, Pages (October 2014)
Principles and Strategies for Developing Network Models in Cancer
Steven K. Schwartz, William E. Wagner, Eileen A. Hebets 
Volume 10, Issue 6, Pages (December 2006)
Volume 5, Issue 4, Pages e4 (October 2017)
Volume 29, Issue 5, Pages (May 2016)
Volume 66, Issue 4, Pages e4 (May 2017)
Samirkumar B. Amin, Roel G.W. Verhaak  Cell Systems 
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Volume 17, Issue 5, Pages (October 2016)
Volume 26, Issue 12, Pages e5 (March 2019)
Cancer Cell Line Encyclopedia
Volume 16, Issue 11, Pages (September 2016)
Volume 25, Issue 14, Pages (July 2015)
Hyunghoon Cho, Bonnie Berger, Jian Peng  Cell Systems 
Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells  Yue Han, Chengyu Wang, Qi Dong, Tingting Chen,
Mutational Analysis of Ionizing Radiation Induced Neoplasms
Volume 28, Issue 3, Pages e7 (July 2019)
Volume 3, Issue 6, Pages e3 (December 2016)
Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery  Chen-Tsung Huang, Chiao-Hui Hsieh, Yun-Hsien Chung, Yen-Jen Oyang, Hsuan-Cheng.
A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.
Global analysis of the chemical–genetic interaction map.
An isogenic cell line screen reveals genomic drivers of drug response.
Collin Tokheim, Rachel Karchin  Cell Systems 
High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies. High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies.
Volume 28, Issue 4, Pages e6 (July 2019)
Synthetic lethality of ROS1 inhibition in E-cadherin–deficient breast tumor cell lines. Synthetic lethality of ROS1 inhibition in E-cadherin–deficient.
Fig. 3 Gene expression analysis in 48-plex drug treatment experiments.
Presentation transcript:

CancerGD: A Resource for Identifying and Interpreting Genetic Dependencies in Cancer  Stephen Bridgett, James Campbell, Christopher J. Lord, Colm J. Ryan  Cell Systems  Volume 5, Issue 1, Pages 82-86.e3 (July 2017) DOI: 10.1016/j.cels.2017.06.002 Copyright © 2017 The Authors Terms and Conditions

Cell Systems 2017 5, 82-86.e3DOI: (10.1016/j.cels.2017.06.002) Copyright © 2017 The Authors Terms and Conditions

Figure 1 CancerGD Overview Loss-of-function screens from multiple sources are integrated with exome and copy-number profiles from the GDSC resource. Cell lines are annotated according to the mutational status of a panel of driver genes (see Table S1). Statistical analysis is then performed to identify associations between the presence of driver gene alterations and sensitivity to reagents targeting specific genes. These CGDs are filtered such that only those with nominal significance (p < 0.05) and moderate common language effect sizes (≥65%) are retained. Finally, all CGDs are annotated according to whether they occur between driver-target pairs with known functional relationships (STRING) and whether there is an inhibitor available for the target gene (DGIdb). Cell Systems 2017 5, 82-86.e3DOI: (10.1016/j.cels.2017.06.002) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Genetic Dependency Exploration and Visualization (A) The principle view of the database. Each row represents a gene identified as a dependency associated with ERBB2 amplification in Campbell et al. (2016) across all tumor types (Pan cancer). Columns display experimental details along with the p value, common language effect size, and difference in median sensitivity score for each dependency. Genes identified as dependencies in multiple datasets are indicated in the Multiple Hit column. Genes with a known functional relationship to the driver gene (e.g., PIK3CA) are indicated in the String Interaction column, and drugs known to inhibit the target gene are indicated in the Inhibitors column. Toggles/search boxes permit easy filtering of interactions, e.g., to select only those genes with an associated inhibitor available. See also Figure S1 and the tutorial in Methods S1. (B) Example boxplot showing an increased sensitivity of ERBB2-amplified cell lines to inhibition of MAP2K3. Each data point represents the sensitivity of a particular cell line to RNAi reagents targeting MAP2K3. Cell lines are grouped according to ERBB2 amplification status with the wild-type group on the left and amplified group on the right. Cell lines are colored according to site of origin and toggles on the right permit the hiding/showing of cell lines from specific sites. Hovering over a given data point provides the cell line's name, the primary site, and the score associated with the RNAi reagent in that cell line. An overlapped box-whisker plot displays the interquartile range and the median for each group. High-resolution PNG images for each boxplot can be downloaded along with a CSV file containing all of the data presented in the boxplot. Links to the target gene (MAP2K3) on external websites are provided at the bottom of the plot. Cell Systems 2017 5, 82-86.e3DOI: (10.1016/j.cels.2017.06.002) Copyright © 2017 The Authors Terms and Conditions